1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
The cannabinoid receptor 2 (CB2 receptor) has attracted considerable interest, mainly due to its potential as a target for therapeutics for treating various diseases that have a neuroinflammatory or neurodegenerative component while avoiding the adverse psychotropic effects that accompany CB1 recept...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2022
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e155f8c981fa43f99cbbbced5bbfc653 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|